These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1538716

  • 1. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
    Kletzien RF, Clarke SD, Ulrich RG.
    Mol Pharmacol; 1992 Feb; 41(2):393-8. PubMed ID: 1538716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
    Hallakou S, Foufelle F, Doaré L, Kergoat M, Ferré P.
    Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells.
    Sandouk T, Reda D, Hofmann C.
    Am J Physiol; 1993 Jun; 264(6 Pt 1):C1600-8. PubMed ID: 8333508
    [Abstract] [Full Text] [Related]

  • 6. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [Abstract] [Full Text] [Related]

  • 7. Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent.
    Kletzien RF, Foellmi LA, Harris PK, Wyse BM, Clarke SD.
    Mol Pharmacol; 1992 Oct; 42(4):558-62. PubMed ID: 1435736
    [Abstract] [Full Text] [Related]

  • 8. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
    Mohapatra J, Sharma M, Singh S, Chatterjee A, Swain P, Balaraman R, Patel PR, Jain MR.
    Pharmacology; 2009 Oct; 84(4):203-10. PubMed ID: 19738399
    [Abstract] [Full Text] [Related]

  • 9. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [Abstract] [Full Text] [Related]

  • 10. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
    Tafuri SR.
    Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
    [Abstract] [Full Text] [Related]

  • 11. Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells.
    Sparks RL, Strauss EE, Zygmunt AI, Phelan TE.
    J Cell Physiol; 1991 Jan; 146(1):101-9. PubMed ID: 1990013
    [Abstract] [Full Text] [Related]

  • 12. 3T3 cells in adipocytic conversion.
    O'Shea Alvarez MS.
    Arch Invest Med (Mex); 1991 Jan; 22(2):235-44. PubMed ID: 1726451
    [Abstract] [Full Text] [Related]

  • 13. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T.
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [Abstract] [Full Text] [Related]

  • 14. Preadipocyte stimulating factor in rat serum: evidence for a discrete 63 kDa protein that promotes cell differentiation of rat preadipocytes in primary cultures.
    Li ZH, Lu ZD, Kirkland JL, Gregerman RI.
    J Cell Physiol; 1989 Dec; 141(3):543-57. PubMed ID: 2687298
    [Abstract] [Full Text] [Related]

  • 15. Insulin down-regulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells.
    Aubert J, Safonova I, Negrel R, Ailhaud G.
    Biochem Biophys Res Commun; 1998 Sep 08; 250(1):77-82. PubMed ID: 9735335
    [Abstract] [Full Text] [Related]

  • 16. The signaling potential of the receptors for insulin and insulin-like growth factor I (IGF-I) in 3T3-L1 adipocytes: comparison of glucose transport activity, induction of oncogene c-fos, glucose transporter mRNA, and DNA-synthesis.
    Weiland M, Bahr F, Höhne M, Schürmann A, Ziehm D, Joost HG.
    J Cell Physiol; 1991 Dec 08; 149(3):428-35. PubMed ID: 1660482
    [Abstract] [Full Text] [Related]

  • 17. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
    Takamura T, Nohara E, Nagai Y, Kobayashi K.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):23-9. PubMed ID: 11430909
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T, Matsui K, Nagao K, Shinkai H, Yonemori F, Wakitani K.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):211-9. PubMed ID: 9932726
    [Abstract] [Full Text] [Related]

  • 19. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
    Hofmann CA, Edwards CW, Hillman RM, Colca JR.
    Endocrinology; 1992 Feb 08; 130(2):735-40. PubMed ID: 1733721
    [Abstract] [Full Text] [Related]

  • 20. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A, Kurosaki E, Nakano R, Hirayama R, Shibasaki M, Shikama H.
    Metabolism; 2000 Mar 08; 49(3):411-7. PubMed ID: 10726922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.